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When mouse L-cells are infected with vesicular stomatitis virus, there is a
decrease in the rate of protein synthesis ranging from 20 to 85% of that in mockinfected cells. Vesicular stomatitis virus, irradiated with increasing doses of UV
light, eventually loses this capacity to inhibit protein synthesis. The UV inactivation curve was biphasic, suggesting that transcription of two regions of the viral
genome is necessary for the virus to become inactivated in this capacity. The first
transcription product corresponded to about 373 nucleotides, and the second
corresponded to about 42 nucleotides. Inhibition of transcription of the larger
product by irradiating the virus with low doses of UV light left a residual inhibition
of protein synthesis consisting of approximately 60 to 65% of the total inhibition.
This residual inhibition could be obviated by irradiating the virus with a UV dose
of greater than 20,000 ergs/mm2 and was thus considered to represent the effect of
the smaller transcription product. In the Rl mutant of C. P. Stanners et al. (Cell
11:273-281, 1977), inhibition of transcription of the larger product sufficed to
restore protein synthesis to the mock-infected level, suggesting that the smaller
transcription product is nonfunctional with respect to protein synthesis inhibition.
It thus appears that the inhibition of protein synthesis by wild-type vesicular
stomatitis virus involved at least two separate viral transcription products, and the
inhibition by the Rl mutant involved only one. Extracts from cells infected with
virus irradiated with low doses of UV light showed a protein synthesis capacity
quite similar to that of their in vivo counterparts, indicating that these extracts
closely reflect the in vivo effects of virus infection.

Vesicular stomatitis virus (VSV) has been
shown to inhibit protein synthesis in suitable
host cells (4, 10, 13, 16, 18, 24, 29). The kinetics
and extent of inhibition are somewhat dependent
on the cell line and virus strain (14, 24). As can
be seen by analysis of the products by polyacrylamide gel electrophoresis, the cellular proteins
are inhibited, whereas the viral proteins flourish.
Stanners et al. (24) and Jaye et al. (10) have
shown that protein synthesis inhibition occurs at
the level of polypeptide chain initiation. Furthermore, Centrella and Lucas-Lenard (4) have observed that virus infection causes a decrease in
initiation factor 2 activity in extracts from infected cells.
Lodish and Porter (13, 14) have suggested that
the inhibition of cellular protein synthesis results
from competition between viral and cellular
mRNAs for existing ribosomes. This rationale
follows if one considers that with viral infection,
there is a two- to threefold increase in total
translatable mRNA within 4 h of infection (10,
13, 14). This large increase in total mRNA
618

results from the extremely efficient transcription
of the viral genome.
Other data, however, suggest that specific
viral products other than viral mRNAs are involved in the inhibition (16-18, 24). Stanners et
al. (24) have called the virus-specific product
involved in the inhibition the P function, and
they have isolated and partially characterized a
P- mutant (Rl) that has a lower capacity to
inhibit total protein synthesis than does its parent wild type. Using UV light-inactivated virus,
Marvaldi et al. (17) have found that the inhibition of protein synthesis correlates with the
expression of the N protein gene. Such UVirradiated virus is incapable of secondary transcription, and thus the total number of transcripts in cells infected with this virus is greatly
reduced (6).
In an effort to understand the inhibition phenomenon, we chose the UV light inactivation
technique to construct viruses that express the
inhibitory factor(s), yet do not produce significant amounts of viral mRNA. This technique
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can be used

because viral mRNA transcription is
sequential (1, 2) and therefore allows a successive inhibition of viral mRNA transcription (the
most UV-resistant transcript being that nearest
the transcription initiation site and the least UVresistant being that furthest from that site). Our
results show that the UV-inactivation curve was
biphasic with the HR strain of the Indiana serotype of VSV and monophasic with the Rl mutant characterized by Stanners et al. (24). These
results suggest that protein synthesis inhibition
by the HR strain involves at least two viral
transcription products and that the Rl mutant
probably lacks one of these.
Finally, we prepared cell-free extracts from
the UV-irradiated, virus-infected cells and found
that the protein synthesis capacity of these extracts reflected quite closely that of their in vivo
counterparts. Therefore, these extracts will enable us to dissect the molecular mechanism of
protein synthesis inhibition by VSV.
MATERIALS AND METHODS
Cells and virus. Monolayers of mouse L-cells were
grown and maintained in Richter minimal essential
medium (Irvine Scientific Co.) plus 5% bovine calf
serum on plastic petri dishes at 37°C.
A heat-resistant strain of the Indiana serotype (HRC) of VSV was used throughout this study (8). The
preparation, storage, and analysis of this virus have
been described previously (10). The titer of this virus
stock was typically found to be 1.10 x 101"
0.25 x
1011 PFU/ml. The Rl mutant used in this study was
isolated by Stanners et al. (24). It is a revertant of the
double mutant T1026 and was generously supplied to
P. I. Marcus at the University of Connecticut by C. P.
Stanners. The Rl mutant was grown on Vero-Cl cells,
and the supermatant from these cells was collected at
18 h after infection. The clarified supernatant (10,000
x g for 10 min) was used as stock virus. Its titer was
typically 109 PFU/ml.
Infection of L-cells was essentially the same as
described previously by Wu and Lucas-Lenard (30).
Adsorption was for 45 min at 37°C.
UV irradiation of virus. The virus stock was diluted
(ca. 1/1,000) with phosphate-buffered saline to a concentration that would allow delivery of the desired
multiplicity of infection (MOI). The diluted virus was
transferred to a prewetted Falcon dish and kept on ice.
The virus was then irradiated with UV (average wavelength [X], 254 nm) light from a General Electric
germicidal bulb. The lamp was calibrated against a
Blak-Ray ultraviolet meter (J-22S shortwave UV meter; Ultraviolet Products, Inc.). At 90.5 cm from the
sample, the output of the lamp was 7.3 ± 1.0 ergs/mm2
per s; at 39.5 cm, the output was 26.0 ± 1.0 ergs/mm2
per s. The sample was then transferred to a sterile
plastic tube and kept on ice until used for infection.
Isotope labeling. Double-isotope labeling was performed essentially as described previously by Marvaldi et al. (17). L-cells were prelabeled with 33.3 ,uCi
of 3H-amino acids mixture (NET-250; New England
Nuclear Corp.) per ml in Richter minimal essential
medium plus 5% bovine calf serum for 2 to 4 h and

619

pulse-labeled with 3 to 5 ,uCi of L-[35S]methionine
(specific activity, >1,000 Ci/mmol; NEG-009T; New
England Nuclear Corp.) in Richter minimal essential
medium plus 5% bovine calf serum for 30 min at the
times indicated in the figure legends and table footnotes. The infection was quenched by placing the cells
on ice. The cells were lysed either with 0.4% Triton X100 in RSB (as defined in Jaye et al. [10]) or with 0.1 N
NaOH. The Triton-treated lysates were transferred to
1.5-ml micro test tubes and centrifuged at 13,000 x g
for 5 min. The soluble fractions from the Triton- or
NaOH-treated lysates were neutralized, and then trichloroacetic acid was added to a final concentration of
5%. The Triton-extracted material was heated at 90°C
for 5 min to deacylate the charged tRNA. The trichloroacetic acid precipitates from the Triton- or
NaOH-treated lysates were filtered onto Whatman
GF/C filters and washed with 5 volumes of 5% trichloroacetic acid followed by 5 volumes of 95% ethanol. The dried filters were analyzed in toluene/2a70
(Research Products International Corp.) scintillation
cocktail in a Tracor Mark III scintillation counter
programmed for double-label counting. Repeated experiments have consistently allowed for determinations of ±10o or better.
CeH-free systems. The protocol for the preparation of
the extracts was essentially that described by Jaye et
al. (10). Briefly, L-cells on 100-mm petri dishes were
given fresh medium and serum for 2 h before infection.
The cells were infected with unirradiated or irradiated
virus (MOI, 18 PFU per cell). The infection was
stopped by placing the plates on ice. The cells were
then gently scraped from the plates with a rubber
policeman. The cells were washed twice with ice-cold
Richter minimal essential medium and centrifuged.
The pelleted cells were suspended in 1.5 volumes of
hypotonic buffer (10) for 8 min on ice and then lysed in
a Dounce homogenizer. The lysate was centrifuged at
22,000 x g at 4°C for 15 min. The supernatant fraction
(S-22) was removed and adjusted with 10 times concentrated HKMD, as described previously by Jaye
et al. (10). The conditions for cell-free incubations were as described previously (10). The optimal
Mg2+ concentration for amino acid incorporation was
3.0 mM with extracts from both mock-infected cells
and cells infected with unirradiated (UV = 0
ergs/mm2) virus. The extracts from cells infected with
virus that had been irradiated at doses of 330 or 2,200
ergs/mm2 had broader Mg2+ optima (3 to 6 mM). The
Mg2+ concentration used in each incubation was 3.0
mM, and the ATP concentration was 0.9 mM. The
amount of protein in each lysate was determined as
described previously by Bradford (3). In each incubation, 2 to 5 pCi of L-[35S]methionine (>1,000 Ci/mmol)
was present.
The counts per minute of [35S]methionine incorporated into hot trichloroacetic acid-precipitable material
during 15 min of incubation at 32°C in a 50-pl reaction
mixture was used as a measure of protein synthesis.
The amount of methionine incorporated in terms of
picomoles was calculated by converting counts per
minute to disintegrations per minute and dividing the
disintegrations per minute by the specific radioactivity
of the methionine. The specific radioactivity of the
methionine was determined by measuring the L-methionine pool size for each lysate, using the isotope
dilution technique. The values for the respective ly-
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sates were: mock infected, 34 ,uM; VSV (UV = 0 ergs/

mm2), 33 ,uM; VSV (UV = 330 ergs/mm2), 44 ,uM; and
VSV (UV = 2,200 ergs/mm2), 33 ,uM. Thus, picomoles
of methionine incorporated = disintegrations per minute/(curies of radioactive methionine added/total methionine pool size).
Polyacrylamide gel electrophoresis. The samples and
gels were prepared essentially as described previously
(4), except that the gels were poured as linear gradients from 7.5 to 15% acrylamide. X-Omat AR film
(Eastman Kodak Co.) was used for autoradiography.
Target size analysis. Target size analysis has been
described elsewhere (12). Briefly, the general expression for one-hit multitarget kinetics is NINO = me-rF,
where No is the number of targets present before
irradiation, N is the number of surviving targets, F is
the radiation dose (ergs per square millimeter), r is the
cross section for inactivation, or rather, the target size
(square millimeters per ergs), and m is the number of
targets which must be hit to cause an inactivation
event. Thus, the "surviving fraction" is NINO. In the
actual experiment for protein synthesis inhibition, the
surviving fraction was computed as N = (rate of
synthesis in mock-infected cells - rate in cells infected
with irradiated virus)/rate in mock-infected cells and
No = (rate of synthesis in mock-infected cells - rate in
cells infected with irradiated virus)/rate in mock-infected cells.
Infectivity analysis was used as a calibration of the
rate of inactivation, since one hit to any part of the
genome is necessary and sufficient to inactivate replication. The size of the VSV (HR-C) genome was
assumed to be 3.6 x 106 daltons (27). The slope of the
curve for survival of protein synthesis inhibition as a
function of UV dose, relative to the slope of the curve
for survival of infectivity, was used to calculate the
fractional amount of the genome required to inhibit

protein synthesis.

RESULTS
The effect of UV-irradiation on the ability of
VSV to inhibit protein synthesis. Using UV irradiation to inactivate the viral genome, Marvaldi
et al. (17) showed that there is a correlation
between protein synthesis inhibition and expression of the N protein gene. To obtain a better
estimate of the target size necessary for protein
synthesis inhibition, we UV irradiated the virus
at different doses and then measured the ability
of those irradiated virus preparations to inhibit
protein synthesis. The protein synthesis rate
was determined by pulse-labeling cells for 30
min with [35S]methionine and measuring
[35S]methionine incorporation into hot trichloroacetic acid-insoluble material. In L-cells infected with VSV that had been irradiated with doses
of up to 550 ergs/mm2, there was an apparent
increase in the inhibition of protein synthesis
(Fig. 1A, upper curve). Analysis of the radiolabeled products from this experiment by polyacrylamide gel electrophoresis (Fig. 1B) revealed that the increase was, in fact, a result of a
decrease in viral protein synthesis. The gel anal-
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FIG. 1. Effect of UV-inactivated VSV on b-cell
protein synthesis. b-cells were prelabeled with
L-3H-anino acids for 2 h in fresh medium and serum.

The cells were infected at an MOI of 50 PFU per cell
with VSV that had been irradiated to the indicated
degree or were mock infected with phosphate-buffered
saline. The infected monolayer (0) or suspension
culture (A) of L-cells was incubated for 3.0 or 5.0 h,
respectively, at 370C, then pulse-labeled for 0.5 h at
370C with L-[35S]methionine in complete medium, except for methionine, which was present at 10iM, plus
5% dialyzed bovine calf serum. The infection was
quenched, and a lysate was prepared with Triton, as
described in the text. (A) Inhibition of protein synthesis by UV-irradiated virus. (B) Autoradiogram from a
sodium dodecyl sulfate-gel electrophoresis analysis in
which 100 jg of protein per lane was loaded: (A)
unirradiated, (B) 100 ergS/MM2, (C) 220 ergs/mm', (D)
330 ergs/mm', (E) 440 ergs/mm', (F) 550 ergs/mm', (G)
660 ergs/mm', (H) 1,100 ergS/MM2, (I) 2,200 ergS/MM2,
(J) mock infected, (K) unirradiated. L, L protein; G, G
protein; N/NS, N and NS proteins; M, M protein.
Arrows, b-cell proteins reappearing at high UV doses

(see text).

ysis also showed that at a dose between 440 and
550 ergs/mM2 (lanes E and F), the point of
maximal protein synthesis inhibition, the N protein was the only viral protein detected. It is
most important to note that cellular protein
synthesis was severely inhibited after infection
even when viral protein synthesis (and presumably viral mRNA synthesis) was drastically reduced.
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FIG. 2. Analysis of extracts prepared from L-cells
infected with UV-irradiated VSV. The preparation,
incubation conditions, and analysis of the cell-free
systems are described in the text. Symbols: 0 , mock
infected; 0, VSV (UV = 0 ergs/mmZ);W, VSV (UV =
330 ergslmm2);0 , VSV (UV = 2,200 ergs/mm2).Met,
Methionine.
Infecton of L-cells with VSV irradiated at
doses greater than 550 ergs/mm2 resulted in a
decreasing degree of protein synthesis inhibition
(Fig. lA), and, as shown by the arrows in Fig.
l B , several host proteins began to reappear.
Interestingly, even up to a dose of 3,500
ergs/mm2 (Fig. lA), there was a detectable
amount of protein synthesis inhibition. This residual amount varied from experiment to experiment and ranged from a minimum of 15% to a
maximum of 50%.
On some occasions (2 of 10 experiments) after
infection of cells in monolayers or suspension
culture, the UV inactivation curve looked somewhat different; the initial point (0 ergs/mm2)
represented the maximal amount of inhibition,
and after UV irradiation, the inhibition was less
and less (see lower curve in Fig. 1A). We have
no satisfactory explanation for this observation
at the moment, and studies designed to clarify
this phenomenon are under way in our laboratory.
Comparison of [35~]rnethionineincorporation
into protein in whole cells and in cell-free extracts.
In these studies, we examined the extent to
which extracts from infected cells reflected the
effects of virus infection in vivo. We based these
studies on the observation that when VSV is
irradiated with different doses of UV light, protein synthesis is inhibited to various extents. We
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rationalized that extracts prepared from cells
infected with irradiated virus should reflect the
in vivo protein synthesis activity of the cells.
L-cells in monolayer cultures were mock infected or infected with unirradiated or irradiated
vims, and 3.75 h after infection some of the
cultures were harvested and lysed as described
above. The remaining cultures were pulse-labeled with [35S]methioninein vivo at the same
time, so that in vitro and in vivo rates of protein
synthesis could be compared.
The amino acid pool size was estimated for
each extract (mock infected, UV = 0, 330, or
2,200 ergs/mm2) by isotope dilution techniques,
and the incorporation data were corrected for
differences in pool sizes, as discussed above.
Incorporation of L-[35S]methioninewas maximal
in the extract from mock-infected cells and
minimal in the extract from cells infected with
vims irradiated at a dose of 330 ergs/mm2 (Fig.
2). The extract from cells infected with unirradiated virus was less active than the mock-infected extract, but more active than the extracts
from cells infected with virus irradiated at a dose
of 330 or 2,200 ergs/mm2. Hence, the cell-free
lysates reflected to the whole cell experiments
demonstrated in Fig. 1A in the ability of the
lysates to incorporate L-[35S]methionine.
The products of the in vitro radiolabel incorporation experiments were examined by polyacrylamide gel electrophoresis and were compared with the products labeled in vivo. There
was a good qualitative correlation between the
in vitro- and the in vivo-labeled products (Fig.
3). (These gels cannot be viewed as quantitative
indicators of protein synthesis, since the samples labeled in vitro contained slightly different
amounts of protein.) Fig. 3 also shows the
presence of two apparently vims-specific bands
migrating below the M protein in the gels of both
in vivo- and in vitro-labeled proteins. The origin
of the bands is unknown, and they disappeared
after UV irradiation of the virus. Also, they
were not always detected (Fig. 1B). Currently,
we are trying to characterize these bands. When
initiator [3SS]methionyltRNA in the presence of
100 p,M L-methionine was used in place of L[35S]methionine to label proteins in extracts,
similar results were obtained with respect to
relative incorporation and labeled products
made (data not shown). Thus, both elongation
and initiation were taking place in these extracts.
Quantitatively, when the percentage of protein synthesis (protein synthesis in infected
cells/protein synthesis in mock-infected cells)
was compared, there was a fair correlation between the in vivo and in vitro labeling experiments, as shown in Table 1. The lysates from
cells infected with vims which had been irradiat-
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TABLE 1. Comparison of in vivo with in vitro
protein synthesis activities of UV-irradiated virusinfected cellsa
W dose

(er&mm2)

% of mock-infected
cell activity

In vivo

In vitro
-

0
330
2,200

66
53
65

-

-

63
42
53

" L-cells were infected as described in the text. For
the in vivo values, two plates for each condition were
pulse-labeled from 3.5 to 4.0 h after infection with
[35S]methioninein complete medium, except for methionine, which was present at 10 pM, and 5% dialyzed calf serum. These cells were extracted with
Tritqn and prepared as described in the text. Protein
quantity was determined for each extract, and the
incorporation was computed as counts per minute per
microgram of protein. Values from the in vitro assay
were extracted from the linear region of the curves
from Fig. 2. Values shown were computed from:
picomoles of methionine incorporated per 200 pg of
protein.

FIG. 3. Comparison of the gel electrophoretic patterns of proteins from mock-infected or VSV-infected
L-cells labeled in vivo or in vitro. This is an autoradiogram of an electrophoretic analysis on a 7.5 to 15%
polyacrylamide gel. Lanes 1 through 4, Cells pulselabeled in vivo at 3.5 to 4.0 h after infection and lysed
with Triton; 100 pg protein was added in each lane.
Lanes 5 through 8, Cell-free incubations described in
the text and depicted in Fig. 2: lane 5, 126 pg of
protein; lane 6, 175 pg of protein; lane 7, 159 pg of
protein; and lane 8,170 pg of protein. Lanes 1 and 5,
mock infected; lanes 2 and 6, unirradiated virus; lanes
3 and 7, virus irradiated at 330 ergs/mm2;and lanes 4
and 8, virus irradiated at 2,200 ergs/mm2.The autoradiogram of the proteins labeled in vitro (lanes 5
through 8) was exposed for 10 days, whereas that of
the proteins labeled in vivo (lanes 1 through 4) was
exposed for 4 days. L, L protein; G, G protein; NMS,
N and NS proteins; M, M protein.

ed at a dose of 330 or 2,200 ergs/mm2 were
slightly less active than their in vivo counterparts.
Analysis of small viral transcription product
necessary for protein synthesis inhibition. Cellular protein synthesis was still inhibited from 15
to 40% at UV doses in which transcription
would have been reduced to
of that with
unirradiated virus (Fig. 1A and B; Table 1 and
Fig. 4). This latter value was determined by a
plaque reduction assay at a UV dose of 440
ergs/mm2, and the calculation was based on the
assumption that one hit anywhere in the viral

genome would inhibit replication and therefore
secondary transcription. These results suggested that protein synthesis inhibition involved still
another viral component that was less sensitive
or insensitive to UV irradiation.
The characteristics of this second component
were examined first by determining the time
necessary for expression of protein synthesis
inhibition. If virion proteins would suffice, then
one might expect to see inhibition soon after
virus adsorption. In cells that were infected by
virus that had received a UV light dose of 4,400
ergslmm2, there was little inhibition until 2.25 h
after infection, at which time a 33% inhibition
was observed (Table 2). At 24 h after infection
the inhibition was 40%, suggesting that the effect
was stable. Since the inhibition was time dependent, it seemed probable that transcription of the
viral genome was necessary. This suggestion
was supported by the observation that when the
virus was heated to 50°C under conditions in
which virion-associated transcriptase activity
was lost (13, the virus was no longer capable of
inhibiting cellular protein synthesis (data not
shown). Also, when the virus was subjected to
very lar e doses of UV irradiation (>18,000
ergslmm4), it lost its capacity to inhibit cellular
protein synthesis (data not shown). The product
inactivated at this high UV dose will henceforth
be referred to as the small transcription product.
The other viral product that was inactivated by
UV doses of up to 1,000 ergs/mm2 will be called
the large transcription product.
Analysis of a P- mutant. We wished to determine if the R1 mutant of Stanners et al. (24)

.TION OF PROTEIN SYNTHESIS BY VSV
TABLE 2. Rate and multiplicity dependence of
appearance of small transcription product
% of mock-infected cell activitybat the following dose for MOI (PFUIcell)' of:
Time after
adsop 4,400 ergs/mm2 UV
0 ergs/mm2 UV
tion, (h)"
2.1
21
2.1
21

0.25
1.25
2.25
24

90
93
77
ND

98
93
77

NDd
ND
61

ND
ND
59

60

" L-cell monolayers were infected or mock infected
as described in the text. The cells were pulse-labeled
for 30 min at the indicated times with 3H-amino acids
in complete medium plus 5% dialyzed calf serum.
The cells were extracted with Triton, as described
in the text, the protein quantity was determined for
each sample, and the incorporation was computed as
counts per minute per microgram of protein.
' Stock virus was diluted to yield an MOI of 21.
Then after irradiation, a portion was diluted 1/10 for an
MOI of 2.1.
ND, Not done.
showed the same UV inactivation curve for
protein synthesis inhibition as the wild type.
Subconfluent monolayers of L-cells were infected with UV-irradiated R1 mutant at three differ-

FIG. 4. Effect of UV-irradiated wild-type and R1
virus on L-cell protein synthesis. L-cells were treated
as described in the legend to Fig. 1. Virus was irradiated to the indicated degree. The infected or mockinfected cells were incubated for 3.5 h a t 37'C and then
pulse-labeled with L-[35S]methioninein complete medium plus bovine calf serum for 0.5 h at 37OC. The
infection was quenched, and the medium was extracted with 0.1 N NaOH, as described in the text. The
upper three curves represent infections with the R1
virus at three MOIs: (A) 2.4; ( 0 )43;).( 300. The
lower curve represents an infection with the wild-type
virus at an MOI of 13.
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ent MOIs. The data (Fig. 4) showed the presence
of a UV-sensitive region analogous to that of the
wild-type virus. However, inactivation of the
region of the genome specifying the large transcription product resulted in a virus that was
unable to inhibit protein synthesis, suggesting
that the small transcription product was not
inhibitory in this mutant. The inhibition was
found to be multiplicity dependent. The lower
curve on this graph shows the effect of infection
by wild-type VSV on L-cell protein synthesis.
To learn more about the properties of protein
synthesis inhibition by the R1 mutant, we compared the multiplicity dependence of this mutant
with that of the wild-type virus. The data (Fig. 5)
showed a large difference between the wild type
and the mutant in the MOI needed to inhibit
protein synthesis. Three experiments with the
wild-type virus are presented to demonstrate
that regardless of the extent of protein synthesis
inhibition, 63% of the maximal inhibition was
present at an MOI of 1 PFU per cell. This is
compatible with a one-hit kinetic model with
respect to PFU per cell. The maximal inhibition
of protein synthesis for R1 was not reached until
the MOI was 500 PFU per cell (data not shown).
These results fit a kinetic model in which approximately 60 PFU per cell are necessary to
obtain 63% of the maximum inhibition. At the

1

10

20

JD

40

I

Multiplicity of lnfect~on

FIG. 5. Effect of MOI on protein synthesis inhibition in L-cells infected by wild-type VSV or by the R1
mutant. L-cells were treated as described in the text.
Virus was diluted and used to infect L-cells for both
protein synthesis and infectivity measurements. The
abscissa was corrected to the measured titer for each
experiment. The lower three curves represent three
experiments with wild-type virus done on different
dates. The upper curve represents an experiment with
the R1 virus.
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multiplicities of R1 tested, there was no measurable inhibition that could be attributed to the
small transcription product (see Fig. 4).
Target sizes. The target sizes of the UVsensitive regions of the wild-type and of the R1
mutant genomes were determined as described
above. The upper two curves in Fig. 6 represent
the inactivation of the large transcription product inhibitor of protein synthesis. The size of
the wild-type virus inhibitor was calculated to be
373 ? 71 nucleotides and that of the R1 mutant
inhibitor was calculated to be 807 2 125 nucleotides. The solid line in Fig. 6 represents the loss
of infectivity as a function of UV dose.
Figure 7 shows the data for the inactivation of
the small transcription product of the wild-type
virus. The statistical analysis was as described
for Fig. 6. The target size was 42 2 12 nucleotides.
DISCUSSION
This report shows our attempts to define more
precisely the region(s) of the VSV genome necessary for protein synthesis inhibition, using the

UV Dose (ergs/mm2 )

FIG. 6. Target size analysis of the large transcription product of the VSV genome involved in protein
synthesis inhibition. Target size analysis is described
in the text. The loss of infectivity as a function of UV
dose is indicated by the steep solid line. The slope of
this curve was -9.81 x lo-' mm'lerg for the wild-type
virus and -8.42 x lo-' mm'lerg for the Rl mutant.
The loss of protein synthesis inhibition as a function of
UV dose is indicated by the data for the wild-type
virus (0)and the R1 mutant ( 0 ) .The slope of the
f 0.70 x
mm21erg for
curve was -3.56 x
t 1.25 x
the wild-type virus and -7.70 x
mm2/erg for the R1 mutant. These data represent a
composite of six and two independent experiments.
respectively. The data points are the means of the data
collected, and the error bars are the standard deviations of the data collected. The curve drawn through
the points is a least-squares best-fit analysis of all of
the data collected.

01

0

I

I

8
12
U V Dose (wgs/mm x

4

16

FIG. 7. Target size analysis ol' the small transcription product of the VSV genome involved in protein
synthesis inhibition. The target size analysis is described in the text. The loss of protein synthesis
inhibition as a function of UV dose is depicted by two
an experiment in which
independent experiments: (0)
only one data point was taken at each irradiation dose;
( 0 )a second experiment in which four data points
were taken at each irradiation dose and averaged. The
slope of this curve is -4.5 x 1 0 - t 1.08 x lo-' mm2/
erg. The statistical analysis was as described in the
legend to Fig. 6 . .

technique of UV mapping. Wertz and Youngner
(29) suggested that two mechanisms are involved in the inhibition of cell protein synthesis
by VSV: an initial, UV-insensitive inhibition and
a progressive, UV-sensitive inhibition. N o UVinsensitive inhibition of protein synthesis was
detected in our studies. In fact, the UV inactivation curve for protein synthesis inhibition shown
in this paper was biphasic, suggesting that two
transcription products are involved in the inhibition. The target sizes of the two UV-sensitive
regions of the VSV genome were calculated to
be approximately 375 and 42 nucleotides. The
large transcription product inhibitor accounted
for 35 to 40% of the total inhibition, and the
small transcription product inhibitor accounted
for 60 to 65% of the total inhibition. Neither of
these putative inhibitors corresponded in size to
any of the known viral mRNA species.
The origin of these transcripts is uncertain.
Recent reports have noted the presence of several small RNA species during in vitro transcription (9, 20, 21, 23, 26). These small RNAs arise
from the 3'-proximal region of several of the
viral genes and represent the initiation of transcription at defined sites. Their initiation is
independent of that of the leader RNA (5). Some
of the small RNA transcripts are capped (9, 23,
26) and are highly resistant to UV irradiation (9,
26; J. D. Keene. personal communication). The
capped, UV-resistant R N A species are tran-
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scribed from the 3'-proximal region of the N
protein gene and contain a potential ribosome
binding site (7,22). Because of their similarity in
size and UV resistance, these small RNA species may correspond to the putative small transcription product inhibitor reported in this paper. If so, the effect of the inhibitor on protein
synthesis could be to tie up ribosomes, since
initiation of protein synthesis could conceivably
occur on the fragment. Since there are no chain
termination signals on the fragment, ribosomes
would remain stalled, and the 40s and 60s
subunit pools would be depleted.
The putative large transcription product (375
nucleotides) could also be derived from the N
protein gene in view of the recent isolation and
characterization by Banerjee and co-workers
(25; personal communication) of a 9 s viral RNA
species corresponding to the 5'-terminal transcription product of the N protein gene. This 9 s
RNA species is present in vivo and in vitro,
contains approximately 400 nucleotides, is
capped, has three potential ribosome binding
sites, and is transcribed in equal molar quantities
relative to the N protein mRNA.
VSV infection results in the inhibition of cellular RNA synthesis in addition to cellular protein
synthesis (28, 30). The current evidence suggests that the leader RNA, which contains 48
nucleotides ( 9 , is involved in this process (11,
19). If efficient protein synthesis is dependent on
continuous RNA synthesis, then any perturbation in the rate of RNA synthesis would affect
the rate of protein synthesis. Thus, should the
putative small transcription product be identified as leader RNA, its effect on protein synthesis could be a consequence of RNA synthesis
inhibition.
These possible mechanisms are only speculative, and there is no evidence to favor one over
another. It is probable that more than one mechanism is operating, in view of our results with
the R1 mutant. We are in the process of identifying the putative transcription products described
in this report.
The R1 mutant described by Stanners et al.
(24) poses an interesting problem. As shown in
Fig. 4, 5, and 6, the R1 mutant behaved quite
differently from the wild-type virus in a number
of respects. First, a much higher MOI was
needed to elicit inhibition of protein synthesis
(see Fig. 5). One infectious particle per cell was
sufficient for 63% inhibition by the wild-type
virus, whereas as many as 60 infectious particles
per cell were needed by the mutant. Secondly,
the UV inactivation curve was monophasic in
the case of the mutant (Fig. 4), as opposed to
being biphasic in the case of the wild-type virus.
It is possible that the P function is related to the
role of the small transcription product. Our
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preliminary experiments show that in cells infected with the R1 mutant, RNA synthesis inhibition occurred to a much lesser extent than in
cells infected with the wild-type virus. These
findings suggest that there is some link between
RNA and protein synthesis inhibition.
These studies have also reinforced our contention (10) that the inhibition of protein synthesis by VSV does not result from competition
between viral and cellular mRNA species for
available ribosomes in the cell (13, 14). Until a
very high dose of UV irradiation was applied to
VSV, the virus was still capable of inhibiting
protein synthesis. Under these conditions little,
if any, viral mRNA synthesis occurred, as ascertained by the low amount of viral proteins synthesized (see Fig. 1B and Fig. 3).
The comparative study (Fig. 3 and Table 1)of
the translation of the protein products synthesized by unirradiated and UV-irradiated VSV in
vivo and in vitro showed that the same species
of proteins were made. This finding will allow us
to study this inhibition in vitro.
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